Epithalon
Synthetic tetrapeptide studied for telomerase activation, telomere elongation, and circadian melatonin normalisation. Originally derived from pineal gland extract by gerontologist Vladimir Khavinson. Also known as Epitalon.
Lo que Muestra la Investigación
Studied for telomerase reverse transcriptase (TERT) activation, telomere elongation, and circadian rhythm normalisation via pineal modulation. Studies measure telomere length (qPCR T/S ratio), TERT mRNA, and melatonin secretion. In vitro human cell evidence for telomerase activation exists; robust in vivo human data is limited.
Pros y Contras
- +Epithalon: in vitro human cell evidence for telomerase activation — rare and significant for a research peptide
- +GHK-Cu regulates 4,000+ human genes according to transcriptomic analysis — unusually broad biological activity
- +GHK-Cu available in both injectable and topical forms — accessible entry point without injections
- +Decades of research behind both compounds (Khavinson's Epithalon work since the 1980s)
- +No significant toxicity in rodent studies at high doses
- +Epithalon may normalise melatonin secretion — secondary sleep and circadian benefit
- −Epithalon's telomerase activation is demonstrated in vitro (cell cultures); robust in vivo human evidence is limited
- −Theoretical concern: activating telomerase in cells with pre-existing DNA damage could theoretically promote cancer cell survival
- −GHK-Cu topicals have significantly lower penetration than injectable — skin benefits differ in magnitude
- −Epithalon courses are short (10–20 injections) but need to be repeated; total cost accumulates
- −Long-term human safety data for Epithalon is absent in Western regulatory review contexts
- −Longevity effects are inherently difficult to measure in the short term
Cronología de Efectos
Basado en cronologías de estudios publicados. La extrapolación humana es aproximada — los resultados individuales varían significativamente.
GHK-Cu wound healing effects are measurable within 14 days in animal models. Epithalon's telomere effects are assessed at the end of a 10–20 day course in published studies. Circadian and sleep quality improvements from Epithalon are often reported within the first 5–7 days of a course by self-researchers.
Para Qué se Investiga
Preguntas Prácticas
How long is an Epithalon course and how often should it be repeated?
Published Khavinson studies use 10–20 daily subcutaneous injections as a single course. Self-researchers commonly repeat this once or twice per year. There is no established optimal frequency for humans — annual or biannual cycling is based on the schedule used in animal longevity studies, not human-specific data.
Which is better for skin: topical or injectable GHK-Cu?
For dermal effects specifically (collagen, wound healing, skin thickness), topical GHK-Cu reaches dermis-level concentrations within hours and is the most practical approach. Injectable GHK-Cu provides systemic distribution that topical cannot achieve. Many self-researchers use both: topical for skin and injectable for systemic effects. Topical products are widely available commercially without requiring peptide sourcing.
Is it safe to take Epithalon if I have a personal or family history of cancer?
This is an important consideration. Telomerase is overexpressed in approximately 90% of human cancers, as it enables cancer cells to replicate indefinitely. Activating telomerase in an individual with pre-existing cellular abnormalities carries theoretical risk. Most published Epithalon studies have not tracked oncological outcomes over long timeframes. This is a question to discuss with a healthcare professional — not a determination we can make from preclinical data alone.
Dónde Comprar Epithalon en Latinoamérica
4 proveedores accesibles para LATAM tienen Epithalon actualmente disponible en stock, incluyendo 2 con envío verificado a LATAM. Compara precios y disponibilidad abajo.